BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 30342013)

  • 1. Recent progress in non-opioid analgesic peptides.
    Pérez de Vega MJ; Ferrer-Montiel A; González-Muñiz R
    Arch Biochem Biophys; 2018 Dec; 660():36-52. PubMed ID: 30342013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor and Molecular Targets for the Development of Novel Opioid and Non-Opioid Analgesic Therapies.
    Chen R; Coppes OJM; Urman RD
    Pain Physician; 2021 Mar; 24(2):153-163. PubMed ID: 33740349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. G-Protein Coupled Receptors Targeted by Analgesic Venom Peptides.
    Daniel JT; Clark RJ
    Toxins (Basel); 2017 Nov; 9(11):. PubMed ID: 29144441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural Insights Accelerate the Discovery of Opioid Alternatives.
    Che T; Roth BL
    Annu Rev Biochem; 2021 Jun; 90():739-761. PubMed ID: 33756098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of pain transmission by G-protein-coupled receptors.
    Pan HL; Wu ZZ; Zhou HY; Chen SR; Zhang HM; Li DP
    Pharmacol Ther; 2008 Jan; 117(1):141-61. PubMed ID: 17959251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Central and peripheral mechanisms in antinociception: current and future perspectives].
    Fürst Z
    Neuropsychopharmacol Hung; 2008 Jun; 10(3):127-30. PubMed ID: 18956616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analgesic conopeptides targeting G protein-coupled receptors reduce excitability of sensory neurons.
    Sadeghi M; McArthur JR; Finol-Urdaneta RK; Adams DJ
    Neuropharmacology; 2017 Dec; 127():116-123. PubMed ID: 28533165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PD-1: A New Candidate Target for Analgesic Peptide Design.
    Zhao L; Ma Y; Song X; Wu Y; Jin P; Chen G
    J Pain; 2023 Jul; 24(7):1142-1150. PubMed ID: 36781089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenetics of new analgesics.
    Lötsch J; Geisslinger G
    Br J Pharmacol; 2011 Jun; 163(3):447-60. PubMed ID: 20942817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging Targets for the Management of Osteoarthritis Pain.
    Malfait AM; Miller RJ
    Curr Osteoporos Rep; 2016 Dec; 14(6):260-268. PubMed ID: 27730452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What is the main mechanism of tramadol?
    Minami K; Ogata J; Uezono Y
    Naunyn Schmiedebergs Arch Pharmacol; 2015 Oct; 388(10):999-1007. PubMed ID: 26292636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potassium channels and pain: present realities and future opportunities.
    Ocaña M; Cendán CM; Cobos EJ; Entrena JM; Baeyens JM
    Eur J Pharmacol; 2004 Oct; 500(1-3):203-19. PubMed ID: 15464034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioids in chronic pain.
    Przewłocki R; Przewłocka B
    Eur J Pharmacol; 2001 Oct; 429(1-3):79-91. PubMed ID: 11698029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The G protein-coupled receptor-transient receptor potential channel axis: molecular insights for targeting disorders of sensation and inflammation.
    Veldhuis NA; Poole DP; Grace M; McIntyre P; Bunnett NW
    Pharmacol Rev; 2015; 67(1):36-73. PubMed ID: 25361914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective analgesic acting via neuronal nicotinic acetylcholine receptors: I. In vitro characterization.
    Donnelly-Roberts DL; Puttfarcken PS; Kuntzweiler TA; Briggs CA; Anderson DJ; Campbell JE; Piattoni-Kaplan M; McKenna DG; Wasicak JT; Holladay MW; Williams M; Arneric SP
    J Pharmacol Exp Ther; 1998 May; 285(2):777-86. PubMed ID: 9580626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antinociceptive activity of chemical congeners of improgan: optimization of side chain length leads to the discovery of a new, potent, non-opioid analgesic.
    Hough LB; de Esch IJ; Janssen E; Phillips J; Svokos K; Kern B; Trachler J; Abood ME; Leurs R; Nalwalk JW
    Neuropharmacology; 2006 Sep; 51(3):447-56. PubMed ID: 16806300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel G protein-coupled receptors as pain targets.
    Ahmad S; Dray A
    Curr Opin Investig Drugs; 2004 Jan; 5(1):67-70. PubMed ID: 14983976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two to tango: GPCR oligomers and GPCR-TRP channel interactions in nociception.
    Yekkirala AS
    Life Sci; 2013 Mar; 92(8-9):438-45. PubMed ID: 22771696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of orphan G protein-coupled receptors in the modulation of pain: A review.
    Nourbakhsh F; Atabaki R; Roohbakhsh A
    Life Sci; 2018 Nov; 212():59-69. PubMed ID: 30236869
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.